Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis

Current Cardiology Reports

Volumn 8, Issue 2, 2006, Pages 102-108

  Winston, Lisa G ^b   Bolger, Ann F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; GENTAMICIN; METICILLIN; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; DATA BASE; DRUG USE; ECHOCARDIOGRAPHY; FOLLOW UP; HUMAN; INCIDENCE; OUTPATIENT CARE; REVIEW; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; HEART VALVE PROSTHESIS; HUMANS; PREVALENCE; RISK FACTORS;

EID: 33645338982     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0020-3     Document Type: Review

References (46)

1. Mylonakis E, Calderwood SB: Infective endocarditis in adults. N Engl J Med 2001, 345:1318-1330.
2. Moreillon P, Que YA: Infective endocarditis. Lancet 2004, 363:139-149.
3. Tleyjeh IM, Steckelberg JM, Murad HS, et al.: Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022-3028.
4. Martin-Davila P, Fortun J, Navas E, et al.: Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005, 128:772-779.
5. Frazee BW, Lynn J, Charlebois ED, et al.: High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005, 45:311-320.
6. Simor AE, Ofner-Agostini M, Bryce E: The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001, 165:21-26.
7. Hogevik H, Olaison L, Andersson R, et al.: Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995, 74:324-339.
8. Strom BL, Abrutyn E, Berlin JA, et al.: Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation 2000, 102:2842-2848.
9. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Gorgolas M: Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995, 20:16-23.
10. Fowler VG Jr, Miro JM, Hoen B, et al.: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
11. Raoult D, Casalta JP, Richet H, et al.: Contribution of systematic serological testing in the diagnosis of infective endocarditis. J Clin Microbiol 2005, 43:5238-5242.
12. Everett ED, Hirschmann JV: Transient bacteremia and endocarditis prophylaxis. Medicine (Baltimore) 1977, 56:61-77.
13. Lockhart PB, Brennan MT, Fox PC, et al.: Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis 2002, 34:1621-1626.
14. Bonow RO, Bonow RO, Cheitlin MD, et al.: Task Force 3: valvular heart disease. J Am Coll Cardiol 2005, 45:1334-1340
15. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA: The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983, 5:54-70.
16. Towns ML, Reller LB: Diagnostic methods current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis. Infect Dis Clin North Am 2002, 16:363-376, ix-x.
17. Das M, Badley AD, Cockerill FR, et al.: Infective endocarditis caused by HACEK microorganisms. Annu Rev Med 1997, 48:25-33.
18. Doern GV, Davaro R, George M, Campognone P: Lack of requirement for prolonged incubation of Septi-Chek blood culture bottles in patients with bacteremia due to fastidious bacteria. Diagn Microbiol Infect Dis 1996, 24:141-143.
19. Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200-209.
20. Li JS, Sexton DJ, Mick N, et al.: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
21. Bayer AS, Bolger AF, Taubert KA, et al.: Diagnosis and management of infective endocarditis and its complications. Circulation 1998, 98:2936-2948.
22. Frontera JA, Gradon JD: Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000, 30:374-379.
23. Chirillo F, Pedrocco A, De Leo A, et al.: Impact of harmonic imaging on transthoracic echocardiographic identification of infective endocarditis and its complications. Heart 2005, 91:329-333.
24. Heidenreich PA, Masoudi FA, Maini B, et al.: Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med 1999, 107:198-208.
25. Rosen AB, Fowler VG Jr, Corey GR, et al.: Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999, 130:810-820.
26. El-Ahdab F, Benjamin DK Jr, Wang A, et al.: Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med 2005, 118:225-229.
27. Rohmann S, Erbel R, Darius H, et al.: Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991, 4:465-474.
28. Baddour LM, Wilson WR, Bayer AS, et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for health-care professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:3167-3184.
29. Kuehnert MJ, Hill HA, Kupronis BA, et al.: Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 2005, 11:868-872.
30. Fridkin SK, Hageman JC, Morrison M, et al.: Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444.
31. Miller LG, Perdreau-Remington F, Rieg G, et al.: Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445-1453.
32. Turnidge J: Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am 2003, 17:503-528.
33. Thuny F, Disalvo G, Belliard O, et al.: Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005, 112:69-75.
34. Netzer RO, Altwegg SC, Zollinger E, et al.: Infective endocarditis: determinants of long term outcome. Heart 2002, 88:61-66.
35. Netzer RO, Zollinger E, Seiler C, Cerny A: Infective endocarditis: clinical spectrum, presentation and out-come. An analysis of 212 cases 1980-1995. Heart 2000, 84:25-30.
36. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ: Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003, 290:3207-3214.
37. Hasbun R, Vikram HR, Barakat LA, et al.: Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003, 289:1933-1940.
38. Zamorano J, de Isla LP, Malangatana G, et al.: Infective endocarditis: mid-term prognosis in patients with good in-hospital outcome. J Heart Valve Dis 2005, 14:303-309.
39. Mugge A, Daniel WG, Frank G, Lichtlen PR: Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989, 14:631-638.
40. Sanfilippo AJ, Picard MH, Newell JB, et al.: Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991, 18:1191-1199.
41. Steckelberg JM, Murphy JG, Ballard D, et al.: Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991, 114:635-640.
42. Rohmann S, Erbel R, Gorge G, et al.: Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J 1992, 13:446-452.
43. Di Salvo G, Habib G, Pergola V, et al.: Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001, 37:1069-1076.
44. Steckelberg JM, Murphy JG, Ballard D, et al.: Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991, 114:635-640.
45. Chan KL, Dumesnil JG, Cujec B, et al.: A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003, 42:775-780.
46. Deklunder G, Lecroart JL, Conger JL, et al.: Effects of myocardial contractility on microemboli production by 2mechanical heart valves in a bovine model. Tex Heart Inst J 2000, 27:236-239.